Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-07-07
1991-09-03
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
424 93, 4351721, 435243, 435258, A61K 3900, C12N 1500
Patent
active
050453130
ABSTRACT:
A new mutant strain vaccine, and a corresponding method of immunization, against Toxoplasma in cats is provided which makes use of a reproductively deficient strain of T.gondii, designated T-263. Bradyzoites in tissue cysts from laboratory animals infected with the mutant were fed to cats, which developed immunity against subsequent T.gondii challenge without concomitant shedding of infectious oocysts. The new vaccine eliminates the need for chemoprophylaxis subsequent to primary infection.
REFERENCES:
patent: 4473548 (1984-09-01), Frenkel et al.
Freukel et al., Journal Parasitology, vol. 68, No. 5, pp. 744-748, 1982.
E. R. Pfefferkorn and Lorraine C. Pfefferkorn, Toxoplasma gondii: Isolation and Preliminary Characterization of Temperature-Sensitive Mutants, 9/8/75.
J. K. Frenkel and S. A. Caldwell, Specific Immunity and Nonspecific Resistance to Infection: Listeria, Protozoa, and Viruses in Mice and Hamsters, 3/75.
J. K. Frenkel, MD, PhD, Common Questions on Toxoplasmosis: Veterinary, Medical, and Public Health Considerations, 8/82.
J. K. Frenkel, M.D., PhD, Toxoplasmosis in Cats and Man, Jan.-Feb., 1975.
Marjorie L. Melton and Harley G. Sheffield, Activity of the Anticoccidial Compound, Lasalocid, Against Toxoplasma Gondii in Cultured Cells, 1/17/75.
Harley G. Sheffield and Marjorie L. Melton, Effects of Pyrimethamine and Sulfadiazine on the Intestinal Development of Toxoplasma Gondii in Cats, 10/75.
J. P. Dubey and R. A. Yeary, Anticoccidial Activity of 2-Sulfamoyl-4,4-Diaminodiphenylsulfone, Sulfadiazine, Pyrimethamine and Clindamycin in Cats Infected with Toxoplasma Gondii, 3/77.
Joseph D. Schwartzman and E. R. Pfefferkorn, Pyrimidine Synthesis by Intracellular Toxoplasma Gondii, 7/31/80.
E. R. Pfefferkorn and Lorraine C. Pfefferkorn, Quantitative Studies of the Mutagenesis of Toxoplasma Gondii, 8/78.
J. K. Frenkel and Donald D. Smith, Immunization of Cats Against Shedding of Toxoplasma Oocysts, 1/7/82.
Jacob K. Frenkel, Toxoplasmosis, 1984.
H. Waldeland, E. R. Pfefferkorn, and J. K. Frenkel, Temperature-Sensitive Mutants of Toxoplasma Gondii: Pathogenicity and Persistence in Mice, 7/21/82.
H. Waldeland, and J. K. Frenkel, Live and Killed Vaccines Against Toxoplasmosis in Mice, 7/21/82.
J. K. Frenkel and D. D. Smith, Inhibitory Effects of Monensin on Shedding of Toxoplasma Oocysts by Cats, 2/17/82.
Frenkel Jacob K.
Pfefferkorn Elmer R.
Darmouth College
Mohamed Abdel A.
Moskowitz Margaret
The University of Kansas
LandOfFree
Vaccine for immunizing cats against toxoplasma oocyst shedding does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for immunizing cats against toxoplasma oocyst shedding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for immunizing cats against toxoplasma oocyst shedding will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1007843